长链非编码核苷酸膀胱癌相关转录因子1在咽部鳞状细胞癌中的研究进展
Research Progress on lncRNA BLACAT1 in Pharyngeal Squamous Cell Carcinoma
摘要: 长链非编码核苷酸(long noncoding RNA, IncRNAs)是由200多个核苷酸组成的转录本，由于缺乏开放性阅读框架从而无法编码蛋白质。然而，lncRNAs以多种方式参与基因转录及转录后的多个层面，从而调控肿瘤的发生与发展。其中，长链非编码核苷酸膀胱癌相关转录因子1 (lncRNA BLACAT1)被证实通过与miRNAs竞争性结合、参与Wnt/β-catenin信号通路和STAT3信号通路以及作用于相关蛋白和分子，从而在恶性肿瘤的发生发展过程中起重要的作用。本文中，我们将概括lncRNA BLACAT1在咽部鳞状细胞癌中的作用机制，并预测其将来有望成为咽部鳞状细胞癌的新型生物标志物和治疗靶点。
Abstract: Long noncoding RNAs (lncRNAs) are a class of transcripts that are longer than 200 nucleotides, and since they lack an open reading frame, they do not encode proteins. However, lncRNAs are involved in multiple aspects of gene transcription and post-transcriptional regulation, thereby influencing the oncogenesis and progression of tumors. The long non-coding RNA Bladder Cancer-Associated Transcript 1 (lncRNA BLACAT1) has been confirmed to play a crucial role in the occurrence and de-velopment of malignant tumors by competitively binding with miRNAs, participating in the Wnt/β-catenin signaling pathway and STAT3 signaling pathway, and interacting with relevant pro-teins and molecules. In this paper, we will summarize the mechanism of action of lncRNA BLACAT1 in pharyngeal squamous cell carcinoma and predict that it is expected to become a novel biomarker and therapeutic target for pharyngeal squamous cell carcinoma in the future.
文章引用：开日麦·艾尼瓦尔, 赵辉. 长链非编码核苷酸膀胱癌相关转录因子1在咽部鳞状细胞癌中的研究进展[J]. 临床医学进展, 2024, 14(3): 928-935. https://doi.org/10.12677/ACM.2024.143793

参考文献

[1] Siegel, R.L., Miller, K.D. and Jemal, A. (2019) Cancer Statistics, 2019. CA: A Cancer Journal for Clinicians, 69, 7-34. [Google Scholar] [CrossRef] [PubMed]
[2] 谢小军, 刘家利, 姬荣伟. 长链非编码RNA H19在胆囊癌中的表达及其与临床病理参数和预后的关系[J]. 中国医师杂志, 2019, 21(9): 1373-1376.
[3] Du, X.-H., Wei, H., Qu, G.-X., Tian, Z.-C., Yao, W.-T. and Cai, Q.-Q. (2020) Gene Expression Regulations by Long Noncoding RNAs and Their Roles in Cancer. Pathology-Research and Practice, 216, Article 152983.
[4] Gao, J., Wang, F., Wu, P., Chen, Y. and Jia, Y. (2020) Aberrant lncRNA Expression in Leukemia. Journal of Cancer, 11, 4284-4296. [Google Scholar] [CrossRef] [PubMed]
[5] Malhotra, S., Freeberg, M.-A., Winans, S.-J., Taylor, J. and Beemon, K.-L. (2017) A Novel Long Non-Coding RNA in the hTERT Promoter Region Regulates hTERT Expression. Non-Coding RNA, 4, Article 1. [Google Scholar] [CrossRef] [PubMed]
[6] Liu, Z.-W., Zhao, N., Su, Y.-N., Chen, S.-S. and He, X.-J. (2020) Ex-ogenously Overexpressed Intronic Long Noncoding RNAs Activate Host Gene Expression by Affecting Histone Modi-fication in Arabidopsis. Scientific Reports, 10, Article No. 3094. [Google Scholar] [CrossRef] [PubMed]
[7] Stone, J.-K., Kim, J.-H., Vukadin, L., Richard, A., Giannini, H.-K., Lim, S.-T.S., Tan, M. and Ahn, E.-Y.E. (2019) Hypoxia Induces Cancer Cell-Specific Chromatin Interactions and Increases MALAT1 Expression in Breast Cancer Cells. Journal of Biological Chemistry, 294, 11213-11224. [Google Scholar] [CrossRef] 
[8] Yu, Y., Nangia-Makker, P., Farhana, L. and Majumdar, A.P.N. (2017) A Novel Mechanism of lncRNA and miRNA Interaction: CCAT2 Regulates miR-145 Expression by Suppressing Its Maturation Process in Colon Cancer Cells. Molecular Cancer, 16, Article No. 155. [Google Scholar] [CrossRef] [PubMed]
[9] Ruan, X., Zheng, J., Liu, X., Liu, Y., Liu, L., Ma, J., He, Q., Yang, C., Wang, D., Cai, H., Li, Z., Liu, J. and Xue, Y. (2020) lncRNA LINC00665 Stabilized by TAF15 Impeded the Malignant Biological Behaviors of Glioma Cells via STAU1-Mediated mRNA Degradation. Molecular Therapy-Nucleic Acids, 20, 823-840. [Google Scholar] [CrossRef] [PubMed]
[10] Li, Y.-H., Hu, Y.-Q., Wang, S.-C., Li, Y. and Chen, D.-M. (2020) lncRNA SNHG5: A New Budding Star in Human Cancers. Gene, 749, Article 144724. [Google Scholar] [CrossRef] [PubMed]
[11] Ghafouri-Fard, S., Dashti, S. and Taheri, M. (2020) The HOTTIP (HOXA Transcript at the Distal Tip) lncRNA: Review of Oncogenic Roles in Human. Biomedicine & Pharmacotherapy, 127, Article 110158. [Google Scholar] [CrossRef] [PubMed]
[12] Liu, C., Zhuo, H., Ye, M.-Y., Huang, G.-X., Fan, M. and Huang, X.-Z. (2020) lncRNA MALAT1 Promoted High Glucose-Induced Pyroptosis of Renal Tubular Epithelial Cell by Sponging miR-30c Targeting for NLRP3. The Kaohsiung Journal of Medical Sciences, 36, 682-691. [Google Scholar] [CrossRef] [PubMed]
[13] Lu, H., Liu, H., Yang, X., Ye, T., Lv, P., Wu, X. and Ye, Z. (2019) lncRNA BLACAT1 May Serve as a Prognostic Predictor in Cancer: Evidence from a Meta-Analysis. BioMed Research International, 2019, Article ID: 1275491. [Google Scholar] [CrossRef] [PubMed]
[14] Chen, X., Dai, M., Zhu, H., Li, J., Huang, Z., Liu, X., Huang, Y., Chen, J. and Dai, S. (2017) Evaluation on the Diagnostic and Prognostic Values of Long Non-Coding RNA BLACAT1 in Common Types of Human Cancer. Molecular Cancer, 16, Article No. 160. [Google Scholar] [CrossRef] [PubMed]
[15] 于进涛, 熊新高. EB病毒在鼻咽癌发生机制中的作用[J]. 临床内科杂志, 2019, 36(6): 365-367.
[16] Zhu, M., Li, X., Zhu, S., Li, P., Min, L. and Zhang, S. (2020) Long Non-Coding RNA BLACAT1, a Novel Promising Biomarker and Regulator of Human Cancers. Biomedicine & Phar-macotherapy, 132, Article 110808. [Google Scholar] [CrossRef] [PubMed]
[17] Gou, C., Han, P., Li, J., Gao, L., Ji, X., Dong, F., Su, Q., Zhang, Y. and Liu, X. (2020) Knockdown of lncRNA BLACAT1 Enhances Radiosensitivity of Head and Neck Squamous Cell Carcinoma Cells by Regulating PSEN1. The British Journal of Radiology, 93, Article 20190154. [Google Scholar] [CrossRef] [PubMed]
[18] Ye, T., Yang, X., Liu, H., Lv, P. and Ye, Z. (2020) Long Non-Coding RNA BLACAT1 in Human Cancers. OncoTargets and Therapy, 13, 8263-8272. [Google Scholar] [CrossRef] 
[19] Olivero, C.E., Martinez-Terroba, E., Zimmer, J., Liao, C., Tesfaye, E., Hooshdaran, N., Schofield, J.A., Bendor, J., Fang, D., Simon, M.D., Zamudio, J.R. and Dimitrova, N. (2020) p53 Acti-vates the Long Noncoding RNA Pvt1b to Inhibit Myc and Suppress Tumorigenesis. Molecular Cell, 77, 761-774. [Google Scholar] [CrossRef] [PubMed]
[20] Frank, A.-C., Ebersberger, S., Fink, A.-F., Lampe, S., Weigert, A., Schmid, T., Ebersberger, I., Syed, S.-N. and Brune, B. (2019) Apoptotic Tumor Cell-Derived microRNA-375 Uses CD36 to Alter the Tumor-Associated Macrophage Phenotype. Nature Communications, 10, Article No. 1135. [Google Scholar] [CrossRef] [PubMed]
[21] Ma, M., Xu, H., Liu, G., Wu, J., Li, C., Wang, X., Zhang, S., Xu, H., Ju, S., Cheng, W., Dai, L., Wei, Y., Tian, Y. and Fu, X. (2019) Metabolism-Induced Tumor Activator 1 (MITA1), an Energy Stress-Inducible Long Noncoding RNA, Promotes Hepatocellular Carcinoma Metastasis. Hepatol-ogy, 70, 215-230. [Google Scholar] [CrossRef] [PubMed]
[22] Zhang, R., Li, Y., Hu, B., Lu, Z., Zhang, J. and Zhang, X. (2016) Traceable Nanoparticle Delivery of Small Interfering RNA and Retinoic Acid with Temporally Release Ability to Control Neural Stem Cell Differentiation for Alzheimer’s Disease Therapy. Advanced Materials, 28, 6345-6352. [Google Scholar] [CrossRef] [PubMed]
[23] Ong, S.-M., Biswas, S.K. and Wong, S.-C. (2015) Mi-croRNA-Mediated Immune Modulation as a Therapeutic Strategy in Host-Implant Integration. Advanced Drug Delivery Reviews, 88, 92-107. [Google Scholar] [CrossRef] [PubMed]
[24] He, W., Cai, Q., Sun, F., Zhong, G., Wang, P., Liu, H., Luo, J., Yu, H., Huang, J. and Lin, T. (2013) Linc-UBC1 Physically Associates with Polycomb Repressive Complex 2 (PRC2) and Acts as a Negative Prognostic Factor for Lymph node Metastasis and Survival in Bladder Cancer. Biochimica et Bio-physica Acta (BBA)-Molecular Basis of Disease, 1832, 1528-1537. [Google Scholar] [CrossRef] [PubMed]
[25] Hu, Y., Zheng, L., Zhang, J., Shen, Y., Zhang, X. and Lin, L. (2020) lncRNA-MALAT1 Is a Promising Biomarker for Prognostic Evaluation of Tongue Squamous Cell Carcinoma. European Archives of Oto-Rhino-Laryngology, 277, 3255-3160. [Google Scholar] [CrossRef] [PubMed]
[26] Gao, L., Zhao, A. and Wang, X. (2020) Upregulation of lncRNA AGAP2-AS1 Is an Independent Predictor of Poor Survival in Patients with Clear Cell Renal Carcinoma. Oncology Let-ters, 19, 3993-4001. [Google Scholar] [CrossRef] [PubMed]
[27] Liu, N., Hu, G., Wang, H., Wang, Y. and Guo, Z. (2019) lncRNA BLACAT1 Regulates VASP Expression via Binding to miR-605-3p and Promotes Glioma Development. Journal of Cellular Physiology, 234, 22144-22152. [Google Scholar] [CrossRef] [PubMed]
[28] Liu, C.-A., Chang, C.-Y., Hsueh, K.-W., Su, H.-L., Chiou, T.-W., Lin, S.-Z. and Harn, H.-J. (2018). Migration/Invasion of Malignant Gliomas and Implications for Therapeutic Treatment. Interna-tional Journal of Molecular Sciences, 19, Article 1115.[CrossRef] [PubMed]
[29] Ma, H., Yuan, L., Li, W., Xu, K. and Yang, L. (2018) The lncRNA H19/miR-193a-3p Axis Modifies the Radio-Resistance and Chemotherapeutic Tolerance of Hepatocellular Carcinoma Cells by Targeting PSEN1. Journal of Cellular Biochemistry, 119, 8325-8335. [Google Scholar] [CrossRef] [PubMed]
[30] Chen, Y., Gu, J., Li, D. and Li, S. (2012) Time-Course Network Analysis Reveals TNF-Alpha Can Promote G1/S Transition of Cell Cycle in Vascular Endothelial Cells. Bioin-formatics, 28, 1-4. [Google Scholar] [CrossRef] [PubMed]
[31] Zhang, C., Wang, J., Zhang, J., Qu, H. and Tang, X. (2020) LINC00461 Overexpression Can Induce Docetaxel Resistance in Breast Cancer by Interacting with miR-411-5p. Onco-Targets and Therapy, 13, 5551-5562. [Google Scholar] [CrossRef] 
[32] Hu, X., Liu, Y., Du, Y., Cheng, T. and Xia, W. (2019) Long Non-Coding RNA BLACAT1 Promotes Breast Cancer Cell Proliferation and Metastasis by miR-150-5p/CCR2. Cell & Bioscience, 9, Article No. 14. [Google Scholar] [CrossRef] [PubMed]
[33] Han, W., Yu, F. and Guan, W. (2020) Oncogenic Roles of lncRNA BLACAT1 and Its Related Mechanisms in Human Cancers. Biomedicine & Pharmacotherapy, 130, Article 110632. [Google Scholar] [CrossRef] [PubMed]
[34] Xu, R., Cao, X.R., Zhang, B.Q., Wang, J.L., Wang, L. and Sun, W.Q. (2019) BLACAT1 Is Negatively Associated with Prognosis in Patients with NSCLC and Inhibits Cell Progression, Metastasis and Epithelial-Mesenchymal Transition through Down-Regulating Wnt/beta-Catenin Signaling Pathway. European Review for Medical and Pharmacological Sciences, 23, 6217-6225.
[35] Liao, D., Lv, G., Wang, T., et al. (2018) Prognostic Value of Long Non-Coding RNA BLACAT1 in Patients with Papillary Thyroid Carcinoma. Cancer Cell International, 18, Article No. 47. [Google Scholar] [CrossRef] [PubMed]
[36] Lou, W., Ding, B. and Fu, P. (2020) Pseudogene-Derived lncRNAs and Their miRNA Sponging Mechanism in Human Cancer. Frontiers in Cell and Developmental Biology, 8, Article 85. [Google Scholar] [CrossRef] [PubMed]
[37] Dai, D., Feng, X.-D., Zhu, W.-Q. and Bao, Y.-N. (2019) lncRNA BLACAT1 Regulates the Viability, Migration, and Invasion of Oral Squamous Cell Carcinoma Cells by Targeting miR-142-5p. European Review for Medical and Pharmacological Sciences, 23, 10313-10323.
[38] Ye, J. R., Liu, L. and Zheng, F. (2017) Long Noncoding RNA Bladder Cancer Associated Transcript 1 Promotes the Proliferation, Migration, and Invasion of Nonsmall Cell Lung Cancer through Sponging miR-144. DNA and Cell Biology, 36, 845-852. [Google Scholar] [CrossRef] [PubMed]
[39] Peng, Y., Leng, W., Duan, S. and Hong, M. (2019) Long Noncoding RNA BLACAT1 Is Overexpressed in Hepatocellular Carcinoma and Its Down-Regulation Suppressed Cancer Cell Development through Endogenously Competing against hsa-miR-485-5p. Biomedicine & Pharmacotherapy, 116, Article 109027. [Google Scholar] [CrossRef] [PubMed]
[40] Cheng, H., Tian, J., Wang, C., Ren, L. and Wang, N. (2020) lncRNA BLACAT1 Is Upregulated in Cervical Squamous Cell Carcinoma (CSCC) and Predicts Poor Survival. Repro-ductive Sciences, 27, 585-591. [Google Scholar] [CrossRef] [PubMed]
[41] Qu, R., Hu, C., Tang, Y., Yu, Q. and Shi, G. (2020) Long Non-Coding RNA BLACAT1 Induces Tamoxifen Resistance in Human Breast Cancer by Regulating miR-503/Bcl-2 Axis. Cancer Management and Research, 12, 1771-1777. [Google Scholar] [CrossRef] 
[42] Huang, F.-X., Chen, H.-J., Zheng, F.-X., Gao, Z.-Y., Sun, P.-F., Peng, Q., Liu, Y., Deng, X., Huang, Y.-H., Zhao, C. and Miao, L.-J. (2019) lncRNA BLACAT1 Is Involved in Chemo-resistance of Non-Small Cell Lung Cancer Cells by Regulating Autophagy. International Journal of Oncology, 54, 339-347. [Google Scholar] [CrossRef] [PubMed]
[43] Wu, X., Zheng, Y., Han, B. and Dong, X. (2018) Long Noncoding RNA BLACAT1 Modulates ABCB1 to Promote Oxaliplatin Resistance of Gastric Cancer via Sponging miR-361. Biomedicine & Pharmacotherapy, 99, 832-838. [Google Scholar] [CrossRef] [PubMed]
[44] Yang, H., Qi, Y., Wang, X.-L., Gu, J.-J. and Shi, T.-M. (2020) Down-Regulation of lncRNA BLACAT1 Inhibits Ovarian Cancer Progression by Suppressing the Wnt/beta-Catenin Signaling Pathway via Regulating miR-519d-3p. Molecular & Cellular Biochemistry, 467, 95-105. [Google Scholar] [CrossRef] [PubMed]
[45] Yuan, S., Tao, F., Zhang, X., Zhang, Y., Sun, X. and Wu, D. (2020) Role of Wnt/beta-Catenin Signaling in the Chemoresistance Modulation of Colorectal Cancer. BioMed Research International, 2020, Article ID: 9390878. [Google Scholar] [CrossRef] [PubMed]
[46] Ma, J.-H., Qin, L. and Li, X. (2020) Role of STAT3 Signaling Pathway in Breast Cancer. Cell Communication and Signaling, 18, Article No. 33. [Google Scholar] [CrossRef] [PubMed]
[47] Davidson, G. and Niehrs, C. (2010) Emerging Links between CDK Cell Cycle Regulators and Wnt Signaling. Trends in Cell Biology, 20, 453-460. [Google Scholar] [CrossRef] [PubMed]
[48] Li, X., Qi, S., Ma, D., Fan, J. and Wang, J. (2019) Long Non-Coding RNA BLACAT1 Promotes the Proliferation and Invasion of Glioma Cells via Wnt/beta-Catenin Signaling. Experimental and Therapeutic Medicine, 17, 4703-4708. [Google Scholar] [CrossRef] [PubMed]
[49] Xu, R., Cao, X.-R., Zhang, B.-Q., Wang, J.-L., Wang, L. and Sun, W.-Q. (2019) BLACAT1 Is Negatively Associated with Prognosis in Patients with NSCLC and Inhibits Cell Progres-sion, Metastasis and Epithelial-Mesenchymal Transition through Downregulating Wnt/beta-Catenin Signaling Pathway. European Review of Medical and Pharmacological Sciences, 23, 6217-6225.
[50] Wang, C.-H., Li, Y.-H., Tian, H.-L., Bao, X.-X. and Wang, Z.-M. (2018) Long Non-Coding RNA BLACAT1 Promotes Cell Proliferation, Migration and Invasion in Cervical Cancer through Activation of Wnt/beta-Catenin Signaling Pathway. European Review of Medical and Pharmacological Sciences, 22, 3002-3009.
[51] Kolligs, F.T., Bommer, G. and Goke, B. (2002) Wnt/beta-Catenin/Tcf Signaling: A Critical Pathway in Gastrointestinal Tumorigenesis. Digestion, 66, 131-144. [Google Scholar] [CrossRef] [PubMed]
[52] Shu, D., Xu, Y. and Chen, W. (2020) Knockdown of lncRNA BLACAT1 Reverses the Resistance of Afatinib to Non-Small Cell Lung Cancer via Modulating STAT3 Signalling. Journal of Drug Targeting, 28, 300-306. [Google Scholar] [CrossRef] 
[53] Dong, Z. and Wang, Y. (2019) lncRNA BLACAT1 Accel-erates the Proliferation and Migration of Osteosarcoma Cells through Regulating STAT3. Pathology-Research and Prac-tice, 215, 571-579. [Google Scholar] [CrossRef] [PubMed]
[54] Aalijahan, H. and Ghorbian, S. (2019) Long Non-Coding RNAs and Cervical Cancer. Experimental and Molecular Pathology, 106, 7-16. [Google Scholar] [CrossRef] [PubMed]
[55] Ma, H., Yuan, L., Li, W., Xu, K. and Yang, L. (2018) The lncRNA H19/miR-193a-3p Axis Modifies the Radio-Resistance and Chemotherapeutic Tolerance of Hepatocellular Car-cinoma Cells by Targeting PSEN1. Journal of Cellular Biochemistry, 119, 8325-8335. [Google Scholar] [CrossRef] [PubMed]
[56] Su, J., Zhang, E., Han, L., Yin, D., Liu, Z., He, X., Zhang, Y., Lin, F., Lin, Q., Mao, P., Mao, W. and Shen, D. (2017) Long Noncoding RNA BLACAT1 Indicates a Poor Prognosis of Colorectal Cancer and Affects Cell Proliferation by Epigenetically Silencing of p15. Cell Death & Disease, 8, Article e2665. [Google Scholar] [CrossRef] [PubMed]

为你推荐